DK0815855T3 - Flerfaset blød gelatine-doseringsform - Google Patents

Flerfaset blød gelatine-doseringsform

Info

Publication number
DK0815855T3
DK0815855T3 DK97304607T DK97304607T DK0815855T3 DK 0815855 T3 DK0815855 T3 DK 0815855T3 DK 97304607 T DK97304607 T DK 97304607T DK 97304607 T DK97304607 T DK 97304607T DK 0815855 T3 DK0815855 T3 DK 0815855T3
Authority
DK
Denmark
Prior art keywords
dosage form
soft gelatin
gelatin dosage
multiphase
multiphase soft
Prior art date
Application number
DK97304607T
Other languages
Danish (da)
English (en)
Inventor
Michael R Hoy
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Application granted granted Critical
Publication of DK0815855T3 publication Critical patent/DK0815855T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK97304607T 1996-06-28 1997-06-27 Flerfaset blød gelatine-doseringsform DK0815855T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/671,979 US6024980A (en) 1996-06-28 1996-06-28 Multiphase soft gelatin dosage form

Publications (1)

Publication Number Publication Date
DK0815855T3 true DK0815855T3 (da) 2003-01-06

Family

ID=24696660

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97304607T DK0815855T3 (da) 1996-06-28 1997-06-27 Flerfaset blød gelatine-doseringsform

Country Status (24)

Country Link
US (1) US6024980A (fr)
EP (1) EP0815855B1 (fr)
JP (1) JPH10182437A (fr)
KR (1) KR980000438A (fr)
CN (1) CN1172642A (fr)
AR (1) AR007648A1 (fr)
AT (1) ATE223707T1 (fr)
AU (1) AU2620197A (fr)
BR (1) BR9703771A (fr)
CO (1) CO4900025A1 (fr)
CZ (1) CZ205697A3 (fr)
DE (1) DE69715319T2 (fr)
DK (1) DK0815855T3 (fr)
ES (1) ES2183089T3 (fr)
HU (1) HUP9701113A2 (fr)
ID (1) ID17794A (fr)
IL (1) IL121145A0 (fr)
NO (1) NO972963L (fr)
NZ (1) NZ328182A (fr)
PL (1) PL320815A1 (fr)
PT (1) PT815855E (fr)
SG (1) SG54525A1 (fr)
TN (1) TNSN97111A1 (fr)
ZA (1) ZA975767B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
CA2363842C (fr) 1999-02-26 2006-01-10 Shionogi & Co., Ltd. Capsules molles a croquer presentant des proprietes d'ingestion ameliorees et leur procede de production
US20030060422A1 (en) 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
WO2003024421A2 (fr) * 2001-09-18 2003-03-27 The North West University Forme posologique de triclosan
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
CA2498798A1 (fr) * 2002-09-20 2004-04-01 Alpharma, Inc. Formulation opioides a liberation prolongee et procedes d'utilisation connexes
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
US20040185032A1 (en) * 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US20050249802A1 (en) * 2004-05-06 2005-11-10 The Procter & Gamble Company Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
AU2010300641B2 (en) 2009-09-30 2016-03-17 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
EP2844235A1 (fr) * 2012-04-13 2015-03-11 Banner Pharmacaps, Inc. Capsules molles élastiques contenant des comprimés et remplies de liquides ou de semi-solides et procédés pour leur fabrication
WO2014085599A1 (fr) 2012-11-30 2014-06-05 Acura Pharmaceuticals, Inc. Libération autorégulée de principe pharmaceutique actif
CA2906633C (fr) * 2013-03-15 2021-11-30 Warner Chilcott Company, Llc Forme posologique de capsule de gelatine molle pharmaceutique comportant de la gomme de guar modifie
CA2919892C (fr) 2013-08-12 2019-06-18 Pharmaceutical Manufacturing Research Services, Inc. Comprime extrude anti-abus a liberation immediate
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9616029B2 (en) 2014-03-26 2017-04-11 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release coated reservoir solid dosage form
EP3169315B1 (fr) 2014-07-17 2020-06-24 Pharmaceutical Manufacturing Research Services, Inc. Forme posologique remplie de liquide anti-abus à libération immédiate
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
US11103581B2 (en) 2015-08-31 2021-08-31 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
BR112020016884A2 (pt) * 2018-02-26 2020-12-15 R.P. Scherer Technologies, Llc Forma de dosagem farmacêutica para uma emulsão de simeticona e loperamida
WO2020047205A1 (fr) * 2018-08-31 2020-03-05 Arctic Therapeutics, Llc Nouvelle formulation topique pour application intradermique et utilisations associées

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59131355A (ja) * 1983-01-17 1984-07-28 森下仁丹株式会社 多重軟カプセルの製法
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
EP0211079A4 (fr) * 1985-01-31 1988-02-15 Fujisawa Pharmaceutical Co Capsule souple a cavites multiples; son procede et appareil de fabrication.
JPS61189230A (ja) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd エトポシド製剤
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
US4639846A (en) * 1985-08-16 1987-01-27 Bbc Brown, Boveri & Company, Limited Method and compensating device for compensating current oscillations
US5209978A (en) * 1985-12-26 1993-05-11 Taisho Pharmaceutical Co., Ltd. Seamless soft capsule and production thereof
DE3600084A1 (de) * 1986-01-03 1987-07-09 Scherer Gmbh R P Formkoerper sowie verfahren und vorrichtung zur herstellung eines solchen formkoerpers
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
DE3727894A1 (de) * 1987-08-21 1989-03-02 Stephan Dieter Kapsel fuer pharmazeutisch wirksame inhaltsstoffe einer droge
FR2624012B1 (fr) * 1987-12-07 1991-05-31 Fdb Ste Civile Rech Nouvelles compositions pharmaceutiques a action hypnotique a base d'hydrate de chloral
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5073384A (en) * 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
GB8926612D0 (en) * 1989-11-24 1990-01-17 Erba Farmitalia Pharmaceutical compositions
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
GB9022788D0 (en) * 1990-10-19 1990-12-05 Cortecs Ltd Pharmaceutical formulations
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
US5501857A (en) * 1992-07-24 1996-03-26 Midwestern Bio-Ag Products & Services, Inc. Oral nutritional and dietary composition
US5683716A (en) * 1993-06-30 1997-11-04 Fujisawa Pharmaceutical Co., Ltd. Encapsulated medicine
US5725846A (en) * 1995-03-02 1998-03-10 The Gillette Company Clear antiperspirant stick containing dibenzylidene alditol and hydroxyalkyl cellulose

Also Published As

Publication number Publication date
CN1172642A (zh) 1998-02-11
JPH10182437A (ja) 1998-07-07
DE69715319T2 (de) 2003-01-23
ID17794A (id) 1998-01-29
HUP9701113A2 (hu) 1998-08-28
PL320815A1 (en) 1998-01-05
ES2183089T3 (es) 2003-03-16
NO972963D0 (no) 1997-06-25
CZ205697A3 (cs) 1998-01-14
AU2620197A (en) 1998-01-15
BR9703771A (pt) 1998-09-01
MX9704846A (es) 1998-07-31
HU9701113D0 (en) 1997-08-28
DE69715319D1 (de) 2002-10-17
IL121145A0 (en) 1997-11-20
ZA975767B (en) 1998-12-28
NZ328182A (en) 1998-11-25
EP0815855B1 (fr) 2002-09-11
NO972963L (no) 1997-12-29
CO4900025A1 (es) 2000-03-27
TNSN97111A1 (fr) 2005-03-15
US6024980A (en) 2000-02-15
AR007648A1 (es) 1999-11-10
KR980000438A (ko) 1998-03-30
SG54525A1 (en) 1998-11-16
PT815855E (pt) 2003-01-31
ATE223707T1 (de) 2002-09-15
EP0815855A1 (fr) 1998-01-07

Similar Documents

Publication Publication Date Title
DK0815855T3 (da) Flerfaset blød gelatine-doseringsform
NO952717L (no) Flerfase-strömmingsmåler
DK0783302T3 (da) Lægemidler
DK0703157T3 (da) Blisterpakning
IS5425A (is) Læknislyf
DE69533127D1 (de) Kühlkörper
DE69532553D1 (de) Entwicklungsgerät
DE69535538D1 (de) Entwicklungsgerät
DE69716933D1 (de) Durchflussmesser
DK1017392T3 (da) Lægemiddel
DE69616680D1 (de) Entwicklungsgerät
DE69614582D1 (de) Entwicklungsgerät
DE69707974D1 (de) Entwicklereinheit
DE69517230D1 (de) Entwicklungsgerät
DE69515159D1 (de) Entwicklungsgerät
DE69626633D1 (de) Durchflussmesser
DE69737681D1 (de) Durchflussmesser
DE69820608D1 (de) In gelatine eingekapselte sertarline dosierungsformen
DE69509037D1 (de) Entwicklungsanordnung
DE59510194D1 (de) Dose
DE69726402D1 (de) Filmentwicklungsgerät
DE59600405D1 (de) Gehhilfe
KR960029102U (ko) 가족 납골묘
KR950034352U (ko) 반도체 현상장치
KR960019560U (ko) 개선된 히트싱크